RICARDO LA GROTTA

Allopathic & Osteopathic Physicians|Family Medicine CAROLINA, PR NPI 1851056873

General Payments — all program years on this page

$620.37

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 17
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $601.14 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $601.1416

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $194.385
Novo Nordisk AS $180.354
Medtronic, Inc. $119.051
Lilly USA, LLC $66.614
ABBVIE INC. $27.321
Exact Sciences Corporation $13.431

By program year

Program yearAmountRecords
2022 $19.231
2024 $601.1416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096861792 Novo Nordisk Inc $23.62 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097059819 Novo Nordisk Inc $18.43 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097212448 Novo Nordisk Inc $15.17 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097826903 Novo Nordisk Inc $123.13 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104124688 ABBVIE INC. $27.32 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104414895 AstraZeneca Pharmaceuticals LP $60.22 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105348136 AstraZeneca Pharmaceuticals LP $84.53 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105520755 AstraZeneca Pharmaceuticals LP $13.51 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105624939 AstraZeneca Pharmaceuticals LP $15.15 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105869777 AstraZeneca Pharmaceuticals LP $20.97 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114745715 Exact Sciences Corporation $13.43 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119513919 Medtronic, Inc. $119.05 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135333856 Lilly USA, LLC $18.50 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135333860 Lilly USA, LLC $14.56 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135356777 Lilly USA, LLC $14.26 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135384349 Lilly USA, LLC $19.29 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.